Masimo to acquire SEDline

Irvine, CA-based Masimo (NASDAQ: MASI) has agreed to buy SEDLine, a manufacturer of brain function monitoring devices. The acquisition marks Masimo's commercial entry into the brain function monitoring market. Terms of the acquisition were not disclosed.

Privately-held and backed with a financial investment from Masimo last year, SEDLine was formed with the mission to advance brain function monitoring to improve the care of patients under anesthesia or sedation, according to a Masimo statement.

Covidien (NYSE:COV) acquired SEDLine competitor Aspect Medical in November 2009 for $210 million, Mass Device reports Aspect Medical's BIS technology is a direct competitor with SEDLine's EEG brain function monitors.

- read the Masimo release
- get more from Mass Device

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.